Modulation of Th1/Th2 balance by infliximab rescues postoperative occurrence of small-intestinal inflammation associated with ulcerative colitis. [electronic resource]
- Digestive diseases and sciences Jun 2010
- 1781-4 p. digital
Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
1573-2568
10.1007/s10620-009-0910-5 doi
Adult Anti-Inflammatory Agents--therapeutic use Antibodies, Monoclonal--therapeutic use Biopsy Colitis, Ulcerative--diagnosis Colonic Pouches--adverse effects Digestive System Surgical Procedures--adverse effects Duodenitis--diagnosis Duodenum--drug effects Endoscopy, Digestive System Female Gastrointestinal Agents--therapeutic use Humans Ileostomy--adverse effects Infliximab Pouchitis--drug therapy Proctocolectomy, Restorative--adverse effects Recurrence Th1 Cells--drug effects Th2 Cells--drug effects Tomography, X-Ray Computed Treatment Outcome